The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Plasma-derived Medical Product Market Research Report 2025
Synopsis
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
The global Plasma-derived Medical Product market was valued at US$ 30330 million in 2023 and is anticipated to reach US$ 50750 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.
This report aims to provide a comprehensive presentation of the global market for Plasma-derived Medical Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma-derived Medical Product.
Report Scope
The Plasma-derived Medical Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma-derived Medical Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma-derived Medical Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Others
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma-derived Medical Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
The global Plasma-derived Medical Product market was valued at US$ 30330 million in 2023 and is anticipated to reach US$ 50750 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.
This report aims to provide a comprehensive presentation of the global market for Plasma-derived Medical Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma-derived Medical Product.
Report Scope
The Plasma-derived Medical Product market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasma-derived Medical Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasma-derived Medical Product companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Others
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma-derived Medical Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma-derived Medical Product Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasma-derived Medical Product Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma-derived Medical Product Market Perspective (2019-2030)
2.2 Plasma-derived Medical Product Growth Trends by Region
2.2.1 Global Plasma-derived Medical Product Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plasma-derived Medical Product Historic Market Size by Region (2019-2024)
2.2.3 Plasma-derived Medical Product Forecasted Market Size by Region (2025-2030)
2.3 Plasma-derived Medical Product Market Dynamics
2.3.1 Plasma-derived Medical Product Industry Trends
2.3.2 Plasma-derived Medical Product Market Drivers
2.3.3 Plasma-derived Medical Product Market Challenges
2.3.4 Plasma-derived Medical Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma-derived Medical Product Players by Revenue
3.1.1 Global Top Plasma-derived Medical Product Players by Revenue (2019-2024)
3.1.2 Global Plasma-derived Medical Product Revenue Market Share by Players (2019-2024)
3.2 Global Plasma-derived Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma-derived Medical Product Revenue
3.4 Global Plasma-derived Medical Product Market Concentration Ratio
3.4.1 Global Plasma-derived Medical Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma-derived Medical Product Revenue in 2023
3.5 Plasma-derived Medical Product Key Players Head office and Area Served
3.6 Key Players Plasma-derived Medical Product Product Solution and Service
3.7 Date of Enter into Plasma-derived Medical Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma-derived Medical Product Breakdown Data by Type
4.1 Global Plasma-derived Medical Product Historic Market Size by Type (2019-2024)
4.2 Global Plasma-derived Medical Product Forecasted Market Size by Type (2025-2030)
5 Plasma-derived Medical Product Breakdown Data by Application
5.1 Global Plasma-derived Medical Product Historic Market Size by Application (2019-2024)
5.2 Global Plasma-derived Medical Product Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plasma-derived Medical Product Market Size (2019-2030)
6.2 North America Plasma-derived Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plasma-derived Medical Product Market Size by Country (2019-2024)
6.4 North America Plasma-derived Medical Product Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma-derived Medical Product Market Size (2019-2030)
7.2 Europe Plasma-derived Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plasma-derived Medical Product Market Size by Country (2019-2024)
7.4 Europe Plasma-derived Medical Product Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma-derived Medical Product Market Size (2019-2030)
8.2 Asia-Pacific Plasma-derived Medical Product Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plasma-derived Medical Product Market Size by Region (2019-2024)
8.4 Asia-Pacific Plasma-derived Medical Product Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasma-derived Medical Product Market Size (2019-2030)
9.2 Latin America Plasma-derived Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plasma-derived Medical Product Market Size by Country (2019-2024)
9.4 Latin America Plasma-derived Medical Product Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma-derived Medical Product Market Size (2019-2030)
10.2 Middle East & Africa Plasma-derived Medical Product Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plasma-derived Medical Product Market Size by Country (2019-2024)
10.4 Middle East & Africa Plasma-derived Medical Product Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma-derived Medical Product Introduction
11.1.4 Takeda Revenue in Plasma-derived Medical Product Business (2019-2024)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Plasma-derived Medical Product Introduction
11.2.4 CSL Revenue in Plasma-derived Medical Product Business (2019-2024)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Detail
11.3.2 Grifols Business Overview
11.3.3 Grifols Plasma-derived Medical Product Introduction
11.3.4 Grifols Revenue in Plasma-derived Medical Product Business (2019-2024)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Plasma-derived Medical Product Introduction
11.4.4 Octapharma Revenue in Plasma-derived Medical Product Business (2019-2024)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Detail
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Plasma-derived Medical Product Introduction
11.5.4 Kedrion Revenue in Plasma-derived Medical Product Business (2019-2024)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Detail
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Plasma-derived Medical Product Introduction
11.6.4 LFB Group Revenue in Plasma-derived Medical Product Business (2019-2024)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Detail
11.7.2 Biotest Business Overview
11.7.3 Biotest Plasma-derived Medical Product Introduction
11.7.4 Biotest Revenue in Plasma-derived Medical Product Business (2019-2024)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Detail
11.8.2 BPL Business Overview
11.8.3 BPL Plasma-derived Medical Product Introduction
11.8.4 BPL Revenue in Plasma-derived Medical Product Business (2019-2024)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Detail
11.9.2 RAAS Business Overview
11.9.3 RAAS Plasma-derived Medical Product Introduction
11.9.4 RAAS Revenue in Plasma-derived Medical Product Business (2019-2024)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Detail
11.10.2 CBPO Business Overview
11.10.3 CBPO Plasma-derived Medical Product Introduction
11.10.4 CBPO Revenue in Plasma-derived Medical Product Business (2019-2024)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Detail
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Plasma-derived Medical Product Introduction
11.11.4 Hualan Bio Revenue in Plasma-derived Medical Product Business (2019-2024)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Detail
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Plasma-derived Medical Product Introduction
11.12.4 Tiantan Bio Revenue in Plasma-derived Medical Product Business (2019-2024)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Detail
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Plasma-derived Medical Product Introduction
11.13.4 Shuanglin Bio Revenue in Plasma-derived Medical Product Business (2019-2024)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Detail
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Plasma-derived Medical Product Introduction
11.14.4 Boya Bio Revenue in Plasma-derived Medical Product Business (2019-2024)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Detail
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Plasma-derived Medical Product Introduction
11.15.4 Yuanda Shuyang Revenue in Plasma-derived Medical Product Business (2019-2024)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Detail
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Plasma-derived Medical Product Introduction
11.16.4 Weiguang Bio Revenue in Plasma-derived Medical Product Business (2019-2024)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Detail
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Plasma-derived Medical Product Introduction
11.17.4 Nanyue Bio Revenue in Plasma-derived Medical Product Business (2019-2024)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Detail
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Plasma-derived Medical Product Introduction
11.18.4 KM Biologics Revenue in Plasma-derived Medical Product Business (2019-2024)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Plasma-derived Medical Product Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immune Globulin
Table 3. Key Players of Coagulation Factor
Table 4. Key Players of Albumin
Table 5. Key Players of Others
Table 6. Global Plasma-derived Medical Product Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Plasma-derived Medical Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Plasma-derived Medical Product Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Plasma-derived Medical Product Market Share by Region (2019-2024)
Table 10. Global Plasma-derived Medical Product Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Plasma-derived Medical Product Market Share by Region (2025-2030)
Table 12. Plasma-derived Medical Product Market Trends
Table 13. Plasma-derived Medical Product Market Drivers
Table 14. Plasma-derived Medical Product Market Challenges
Table 15. Plasma-derived Medical Product Market Restraints
Table 16. Global Plasma-derived Medical Product Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Plasma-derived Medical Product Market Share by Players (2019-2024)
Table 18. Global Top Plasma-derived Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medical Product as of 2023)
Table 19. Ranking of Global Top Plasma-derived Medical Product Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Plasma-derived Medical Product Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Plasma-derived Medical Product Product Solution and Service
Table 23. Date of Enter into Plasma-derived Medical Product Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma-derived Medical Product Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Plasma-derived Medical Product Revenue Market Share by Type (2019-2024)
Table 27. Global Plasma-derived Medical Product Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Plasma-derived Medical Product Revenue Market Share by Type (2025-2030)
Table 29. Global Plasma-derived Medical Product Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Plasma-derived Medical Product Revenue Market Share by Application (2019-2024)
Table 31. Global Plasma-derived Medical Product Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Plasma-derived Medical Product Revenue Market Share by Application (2025-2030)
Table 33. North America Plasma-derived Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Plasma-derived Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Plasma-derived Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Plasma-derived Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Plasma-derived Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Plasma-derived Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Plasma-derived Medical Product Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Plasma-derived Medical Product Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Plasma-derived Medical Product Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Plasma-derived Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Plasma-derived Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Plasma-derived Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Plasma-derived Medical Product Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Plasma-derived Medical Product Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Plasma-derived Medical Product Market Size by Country (2025-2030) & (US$ Million)
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Plasma-derived Medical Product Product
Table 51. Takeda Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. CSL Company Detail
Table 54. CSL Business Overview
Table 55. CSL Plasma-derived Medical Product Product
Table 56. CSL Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 57. CSL Recent Development
Table 58. Grifols Company Detail
Table 59. Grifols Business Overview
Table 60. Grifols Plasma-derived Medical Product Product
Table 61. Grifols Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Octapharma Company Detail
Table 64. Octapharma Business Overview
Table 65. Octapharma Plasma-derived Medical Product Product
Table 66. Octapharma Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 67. Octapharma Recent Development
Table 68. Kedrion Company Detail
Table 69. Kedrion Business Overview
Table 70. Kedrion Plasma-derived Medical Product Product
Table 71. Kedrion Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 72. Kedrion Recent Development
Table 73. LFB Group Company Detail
Table 74. LFB Group Business Overview
Table 75. LFB Group Plasma-derived Medical Product Product
Table 76. LFB Group Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 77. LFB Group Recent Development
Table 78. Biotest Company Detail
Table 79. Biotest Business Overview
Table 80. Biotest Plasma-derived Medical Product Product
Table 81. Biotest Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 82. Biotest Recent Development
Table 83. BPL Company Detail
Table 84. BPL Business Overview
Table 85. BPL Plasma-derived Medical Product Product
Table 86. BPL Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 87. BPL Recent Development
Table 88. RAAS Company Detail
Table 89. RAAS Business Overview
Table 90. RAAS Plasma-derived Medical Product Product
Table 91. RAAS Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 92. RAAS Recent Development
Table 93. CBPO Company Detail
Table 94. CBPO Business Overview
Table 95. CBPO Plasma-derived Medical Product Product
Table 96. CBPO Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 97. CBPO Recent Development
Table 98. Hualan Bio Company Detail
Table 99. Hualan Bio Business Overview
Table 100. Hualan Bio Plasma-derived Medical Product Product
Table 101. Hualan Bio Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 102. Hualan Bio Recent Development
Table 103. Tiantan Bio Company Detail
Table 104. Tiantan Bio Business Overview
Table 105. Tiantan Bio Plasma-derived Medical Product Product
Table 106. Tiantan Bio Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 107. Tiantan Bio Recent Development
Table 108. Shuanglin Bio Company Detail
Table 109. Shuanglin Bio Business Overview
Table 110. Shuanglin Bio Plasma-derived Medical Product Product
Table 111. Shuanglin Bio Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 112. Shuanglin Bio Recent Development
Table 113. Boya Bio Company Detail
Table 114. Boya Bio Business Overview
Table 115. Boya Bio Plasma-derived Medical Product Product
Table 116. Boya Bio Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 117. Boya Bio Recent Development
Table 118. Yuanda Shuyang Company Detail
Table 119. Yuanda Shuyang Business Overview
Table 120. Yuanda Shuyang Plasma-derived Medical Product Product
Table 121. Yuanda Shuyang Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 122. Yuanda Shuyang Recent Development
Table 123. Weiguang Bio Company Detail
Table 124. Weiguang Bio Business Overview
Table 125. Weiguang Bio Plasma-derived Medical Product Product
Table 126. Weiguang Bio Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 127. Weiguang Bio Recent Development
Table 128. Nanyue Bio Company Detail
Table 129. Nanyue Bio Business Overview
Table 130. Nanyue Bio Plasma-derived Medical Product Product
Table 131. Nanyue Bio Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 132. Nanyue Bio Recent Development
Table 133. KM Biologics Company Detail
Table 134. KM Biologics Business Overview
Table 135. KM Biologics Plasma-derived Medical Product Product
Table 136. KM Biologics Revenue in Plasma-derived Medical Product Business (2019-2024) & (US$ Million)
Table 137. KM Biologics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma-derived Medical Product Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Plasma-derived Medical Product Market Share by Type: 2023 VS 2030
Figure 3. Immune Globulin Features
Figure 4. Coagulation Factor Features
Figure 5. Albumin Features
Figure 6. Others Features
Figure 7. Global Plasma-derived Medical Product Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Plasma-derived Medical Product Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Plasma-derived Medical Product Report Years Considered
Figure 13. Global Plasma-derived Medical Product Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Plasma-derived Medical Product Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Plasma-derived Medical Product Market Share by Region: 2023 VS 2030
Figure 16. Global Plasma-derived Medical Product Market Share by Players in 2023
Figure 17. Global Top Plasma-derived Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Medical Product as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Plasma-derived Medical Product Revenue in 2023
Figure 19. North America Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Plasma-derived Medical Product Market Share by Country (2019-2030)
Figure 21. United States Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Plasma-derived Medical Product Market Share by Country (2019-2030)
Figure 25. Germany Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Plasma-derived Medical Product Market Share by Region (2019-2030)
Figure 33. China Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Plasma-derived Medical Product Market Share by Country (2019-2030)
Figure 41. Mexico Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Plasma-derived Medical Product Market Share by Country (2019-2030)
Figure 45. Turkey Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Plasma-derived Medical Product Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Takeda Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 48. CSL Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 49. Grifols Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 50. Octapharma Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 51. Kedrion Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 52. LFB Group Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 53. Biotest Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 54. BPL Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 55. RAAS Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 56. CBPO Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 57. Hualan Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 58. Tiantan Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 59. Shuanglin Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 60. Boya Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 61. Yuanda Shuyang Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 62. Weiguang Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 63. Nanyue Bio Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 64. KM Biologics Revenue Growth Rate in Plasma-derived Medical Product Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
